CV/COS Webinar: Clip 1

At Carevive, our mission is to build patient-centric programs and therapies that revolutionize cancer care. Central to our approach is gaining a comprehensive understanding of how patients experience the disease and navigate different stages of therapy and care. This is where Carevive’s data platform comes into play, offering a unique opportunity to delve into the patient journey.

Our platform allows us to study patients with early-stage disease, a prime example being breast cancer, as Dr. Aaron will discuss in this video. However, our commitment to advancing cancer care extends beyond breast cancer to encompass various solid tumors and liquid cancers.

Through the wealth of data we gather and analyze, we gain invaluable insights into patient experiences, treatment outcomes, and care pathways. By harnessing the power of data, we pave the way for more targeted and effective interventions, leading to better outcomes and improved quality of life for cancer patients.

Stay tuned as we continue to unravel the intricate patient journey through data-driven research, bringing us closer to a future where cancer care is truly patient-centric and personalized. Together, we are forging a path towards a brighter future for cancer patients and their families.

Recent Episodes

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…